Watch Ticker

VistaGen Therapeutics, Inc. Common Stock

Go to VistaGen Therapeutics, Inc. Common Stock Website

$2.88

-0.04 (-1.37%)

Live

Previous Close

$2.92

Day Range

$2.82 - $2.94

Previous Day Range

$2.8 - $2.9395

Market Cap

$86.9 million USD

Day Vol.

115121

Previous Day Vol.

126393

Currency

USD

Primary Exchange

Nasdaq

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neur...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks - All You Need to Know About VistaGen Therapeutics Rating Upgrade to Buy

VistaGen Therapeutics (VTGN) has received a rating upgrade to a Zacks Rank #2 (Buy), reflecting an upward trend in earnings estimates, which is a powerful force impacting stock prices. The upgrade positions the company in the top 20% of Zacks-covered stocks in terms of estimate revisions, suggesting the stock might move higher in the near term.

Related tickers: VTGN.

Read Full Article

Zacks Equity Research - Does VistaGen Therapeutics, Inc. (VTGN) Have the Potential to Rally 160% as Wall Street Analysts Expect?

The mean of analysts' price targets for VistaGen Therapeutics, Inc. (VTGN) points to a 160% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Related tickers: VTGN.

Read Full Article

Trending Tickers

Please sign in to view